Xcounter AB (XCT) hit the ground running on announcing it?s admission to AIM today.
The company raised £16 million before expenses at an IPO price of 155p/share, and on listing this morning the shares started trading at a 25% premium at 197p.
Xcounter has developed a new technology for capturing 3D X-ray images which create a considerably higher quality image combined with a lower radiation dose than tradition X-ray machines. The company intends to use the funds raised to complete the development and build the first units with the intention of targeting the mammography and general body imaging sectors of the health-care industry.